NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Braeburn Inc.

Braeburn Inc.

Private
Plymouth Meeting, PennsylvaniaHealthcare & Life Scienceshttps://braeburnrx.com/

Last Round

VC Round

Jan 10, 2018

Total Funding Raised

$88.48M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Braeburn Inc. is a pharmaceutical company that develops and commercializes medications intended for people living with the serious consequences of opioid use disorder.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Mental Health, Drug Discovery, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

opioid use disorderOUDlong-acting injectablebuprenorphineaddiction treatmentmedication-assisted treatmentMATspecialty pharmaCNS disordersextended-release injectiondrug delivery technologyREMSrisk evaluation and mitigation strategymedication adherencedrug diversion prevention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Braeburn Inc. Comps

Public and private peers based on sector, stage, and business model.

Braeburn Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Braeburn Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 10, 2018
Series AMay 22, 2015

Key People

Founding team and executive leadership

Mike Derkacz

President And CEO

Executive Team

Louis Ricigliano

Chief Financial Officer

Executive Team

Braeburn Inc. Investors

Notable investors and investment history

Braeburn Inc. investors
InvestorRounds
Deerfield ManagementVC Round
RA Capital ManagementVC Round
New Leaf Venture PartnersVC Round
Apple Tree PartnersVC Round, Series A
Avista Healthcare PartnersVC Round
Wellington ManagementVC Round
Rock Springs CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 177% MoM, reaching 23.2K.

  • Nov 9, 2025

    Monthly visitors grew 31% MoM, reaching 7.9K.

Braeburn Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Braeburn Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Braeburn Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPlymouth Meeting, Pennsylvania
Employee Range310
Year Founded2012
Last FundingJan 10, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.